CHERAMI logo

CHERAMI

Asia, Guangdong, China, Guangzhou

Description

CHERAMI is a private equity fund management firm.

Investor Profile

CHERAMI has backed more than 6 startups, with 2 new investments in the last 12 months alone. The firm has led 2 rounds, about 33% of its total and boasts 3 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series C, Series B rounds (top funding stages).
  • Majority of deals are located in China, United States.
  • Strong thematic focus on Biotechnology, Medical, Health Care.
  • Led 1 rounds in the past year.

Stage Focus

  • Series A (50%)
  • Series C (17%)
  • Series B (17%)
  • Series Unknown (17%)

Country Focus

  • China (83%)
  • United States (17%)

Industry Focus

  • Biotechnology
  • Medical
  • Health Care
  • Pharmaceutical
  • Artificial Intelligence (Ai)
  • Oncology
  • Health Diagnostics
  • Biopharma
  • Energy
  • Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does CHERAMI frequently co-invest with?

Co-Investments: 1
Lake Bleu Capital
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
Growth Capital Partners
Europe, England, United Kingdom, London
Co-Investments: 1
Huagai Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
Baidu Ventures
Asia, Beijing, China, Beijing
Co-Investments: 1
CDH Investments
Asia, Kowloon, Hong Kong, Kowloon City
Co-Investments: 1
HM Capital
North America, Texas, United States, Dallas
Co-Investments: 1
Dyee Capital
Asia, Fujian, China, Xiamen
Co-Investments: 1
Pan-Lin Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
ABC International
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1

What are some of recent deals done by CHERAMI?

ProteLight Pharmaceuticals

Jiangyin, Jiangsu, China

ProteLight Pharmaceuticals engages in the development and production of antimicrobial peptide drugs and chemical drugs.

BiotechnologyChemicalHealth CarePharmaceutical
Series DJan 4, 2026
NeuShen Therapeutics

Shanghai, Shanghai, China

NeuShen Therapeutics is a biotechnology company trailblazing the future treatment of neurological and psychiatric disorders.

BiotechnologyMedical
Series AApr 18, 2025
MoleculeMind

Haidian, Beijing, China

MoleculeMind is an AI-integrated biotech firm that fuses artificial intelligence with biotechnology to form a new development platform.

Artificial Intelligence (AI)BiotechnologyLife ScienceMedical
Series ASep 13, 2024
Amount Raised: $14,040,000
PVmed

Guangzhou, Guangdong, China

PVmed focuses the AI-enhanced auxiliary diagnosis and treatment.

Artificial Intelligence (AI)Health CareHealth DiagnosticsMedical
Series ADec 22, 2022
Amount Raised: $14,000,000
Sinogen Biopharma

Boston, Massachusetts, United States

Sinogen Biopharma is a developer of innovative drugs with a vision to bridge China's biotech innovation to the US pharma market.

BiopharmaBiotechnologyHealth CareMedicalPharmaceutical
Series BMay 23, 2022
Amount Raised: $10,000,000
GenFleet Therapeutics

Shanghai, Shanghai, China

GenFleet Therapeutics is a biotechnology developer and researcher of molecular pharmaceuticals targeting cancer treatments.

BiotechnologyHealth CareOncologyPharmaceutical
Series CDec 31, 2021
Amount Raised: $78,667,065
Ronbay Technology

Yuyao, Zhejiang, China

Ronbay Technology is a manufacturer of cathode materials for power batteries.

EnergyManufacturing
Series UnknownJan 1, 2018

Find More Investors Like CHERAMI

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

CHERAMI | Pipeseed